During the pathogenesis of liver fibrosis, Ning Lin et al. reported that TGF-β1 treatment ameliorates experimental hepatic fibrosis by inhibiting hepatic stellate cell (HSC) autophagy [36]. This evidence concerns the gene TGFB1 and Hepatic fibrosis.